Definitions - WHO
1 Definitions • Pharmacovigilance • Adverse event • Adverse reaction – Unexpected adverse reaction – Serious adverse reaction • Side effect
Download Definitions - WHO
Information
Domain:
Source:
Link to this page:
Please notify us if you found a problem with this document:
Advertisement
Documents from same domain
INVESTING IN HEALTH FOR ECONOMIC …
www.who.int2 INVESTING IN HEALTH FOR ECONOMIC DEVELOPMENT Report by the Mexican Commission on Macroeconomics and health 3 The …
Macroeconomics, Investing in health for economic, Investing, Health, Economic, Investing in health for economic development, Development
WHO GOOD PRACTICES FOR PHARMACEUTICAL …
www.who.intworking document qas/09.297/rev.2 page 2 schedule for the proposed adoption process of document qas/09.297/rev.2: who good practices for pharmaceutical microbiology laboratories
Microbiology, Good practices for pharmaceutical, Good, Practices, Pharmaceutical, Good practices for pharmaceutical microbiology laboratories, Laboratories
NORMES ET STANDARDS EN INFRASTRUCTURES …
www.who.intnormes et standards en infrastructures et equipements du centre de sante et de promotion sociale, du centre medical avec antenne chirurgicale et du …
Heterotrophic Plate Count Measurement in …
www.who.intWorld Health Organization Sustainable Development and Healthy Environments Heterotrophic Plate Count Measurement in Drinking Water Safety Management
Health, Heterotrophic plate count measurement in, Heterotrophic, Plate, Count, Measurement, World health organization, World, Organization
Annex 3 WHO good manufacturing practices for ...
www.who.int96 Introduction The fi rst WHO draft text on good manufacturing practices (GMP) was prepared in 1967 by a group of consultants at the request of the Twentieth
Annex 5 WHO good distribution practices for …
www.who.int236 1. Introduction Distribution is an important activity in the integrated supply-chain management of pharmaceutical products. Various people and entities are
Good, Practices, Pharmaceutical, Good distribution practices for, Distribution
Annex 2 WHO good practices for pharmaceutical …
www.who.int71 Introduction and scope of document Pharmaceutical microbiology laboratories may be involved in: — sterility testing; — detection, isolation, enumeration and identifi cation of microorganisms
Microbiology, Good practices for pharmaceutical, Good, Practices, Pharmaceutical, Laboratories, Pharmaceutical microbiology laboratories
LABORATORY BIOSAFETY MANUAL - WHO
www.who.intinterim guidelines WHO/CDS/CSR/LYO/2003.4 LABORATORY BIOSAFETY MANUAL SECOND EDITION (REVISED) WORLD HEALTH ORGANIZATION Geneva 2003
Health, Manual, Laboratory, World health organization, World, Organization, Laboratory biosafety manual, Biosafety
Mycobacteriology Laboratory Manual - WHO
www.who.intMycobacteriology Laboratory Manual ii Edita Pimkina, Infectious Diseases and Tuberculosis Hospital Affi liate of Public institution …
Manual, Laboratory, Mycobacteriology laboratory manual, Mycobacteriology
Laboratory Guidelines for enumerating CD4 T …
www.who.intSEA-HLM-392 Distribution: Limited Laboratory Guidelines for enumerating CD4 T Lymphocytes in the context of HIV/AIDS Regional Office for South-East Asia
Guidelines, Laboratory, Laboratory guidelines for enumerating cd4, Enumerating
Related documents
Efficacy and safety of early parenteral anticoagulation as ...
excellence.acforum.orgDec 04, 2014 · © Schattauer 2014 Thrombosis and Haemostasis 112.6/2014 Blood Coagulation, Fibrinolysis and Cellular Haemostasis 1120 Efficacy and safety of early parenteral ...
Safety, Early, Parenteral, Efficacy, Anticoagulation, Safety of early parenteral anticoagulation as
CDSCO - Guidance for Industry
www.cdsco.nic.in•Submission of Clinical Trial Application for Evaluating Safety and Efficacy • Requirements for permission of New Drugs Approval • Post approval changes in biological products: Quality safety and Efficacy Documents • Preparation of the Quality Information for Drug Submission for New Drug Approval:
Guidance, Safety, Industry, Guidance for industry, Efficacy, Safety and efficacy
IEC 62353: Standards for the Safety and Efficacy of ...
www.gossenmetrawattusa.com© 2013 Dranetz Technologies www.gossenmetrawattusa.com 800-372-6832 (U.S & Canada) +1-732-287-3680 (International) The methods of measurement used before initial ...
Standards, Safety, 63532, Efficacy, Standards for the safety and efficacy
DEVELOPMENT SAFETY UPDATE REPORT - ICH
www.ich.orgThe Development Safety Update Report (DSUR) proposed in this guideline is intended to be a common standard for periodic reporting on drugs under development (including
Development, Report, Update, Safety, Development safety update report
Cosmetics Safety, Efficacy, Quality and Regulatory Compliance
www.intertek.comRegulatory Compliance Research & Development Efficacy & Performance Safety Manufacturing Support Distribution Innovation is key to the successful development of novel cosmetics products.
Quality, Regulatory, Safety, Cosmetic, Efficacy, Cosmetics safety, Quality and regulatory
Medicines Control Council : General Information
www.kznhealth.gov.zaRegistration of Medicines General Information 2.01 General information Feb08 v4.doc April 2008 Page1 of 48 MEDICINES CONTROL COUNCIL GENERAL INFORMATION
General, Information, Control, Medicine, Council, General information, Medicines control council, Medicines control council general information
The use of the WHO-UMC system for standardised case ...
www.who.intThe use of the WHO-UMC system for standardised case causality assessment - 3 - have or any other drug taken. For ‘Probable’, on the other hand, the event is ‘unlikely’ to be
Assessment, System, Case, Causality, System for standardised case causality assessment, Standardised
Related search queries
Efficacy, Safety of early parenteral anticoagulation as, Safety, Guidance for Industry, Safety and Efficacy, 62353: Standards for the Safety and Efficacy, Development Safety Update Report, Cosmetics Safety, Efficacy, Quality and Regulatory, Medicines Control Council : General Information, MEDICINES CONTROL COUNCIL GENERAL INFORMATION, System for standardised case causality assessment